Ondansetron: recommended antiemetics for patients with acute pancreatitis? a population-based study.

Wu, Ge; Ma, Yifei; Wei, Wanzhen; Zeng, Jiahui; Han, Yimin; Song, Yiqun; Wang, Zheng; Qian, Weikun

Wu, Ge; Ma, Yifei; Wei, Wanzhen; Zeng, Jiahui; Han, Yimin; Song, Yiqun; Wang, Zheng; Qian, Weikun.

Afiliação

Wu G; Department of General Practice, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Ma Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wei W; Pancreatic Disease Center of Xi'an Jiaotong University, Xi'an, China.
Zeng J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Han Y; Pancreatic Disease Center of Xi'an Jiaotong University, Xi'an, China.
Song Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang Z; Pancreatic Disease Center of Xi'an Jiaotong University, Xi'an, China.
Qian W; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Front Pharmacol ; 14: 1155391, 2023.

Article em En | MEDLINE | ID: mdl-37234720

Palavras-chave

MIMIC-IV; acute pancreatitis; multiple outcomes; ondansetron; recommended dose

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China